New Concepts in the pathogenesis of diabetes mellitus

Advances in Internal Medicine

Volumn 41, Issue , 1996, Pages 285-321

  Ronald Kahn, C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; CLASSIFICATION; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOLOGY; PANCREAS ISLET; REVIEW;

AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMANS; ISLETS OF LANGERHANS;

EID: 0030345682     PISSN: 00652822     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (123)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl JMed 329:977-986, 1993.
2. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979.
3. WHO Expert Committee on Diabetes Mellitus: Second Report, technical report series 1980. Geneva, World Health Organization, 1980, p 646
4. Marble A, Ferguson BD: Diagnosis and classification of diabetes mellitus and the non-diabetic melliturias, in Marble A, Krall LP, Bradley RF, et al (eds):Joslin's Diabetes Mellitus. Philadelphia, Lea & Febiger, 1985, p 332.
5. Zimmet PZ, Tuomi T, Mackay IR, et al: Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. DiabetMed 11:299-303, 1994.
6. Tattersall RB, Fajans SS: A difference between the inheritance of classical juvenile-onset and maturity-onset diabetes of young people. Diabetes 24:44, 1975.
7. Banerji MA, Chaiken RL, Huey H, et al: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Fiatbush diabetes. Diabetes 43:741-745, 1994.
8. 7a. Winter WE, Maclaren NK, Riley RJ, et al: Maturity-onset diabetes in youth in black Americans. N Engl JMed 316:285-291, 1987.
9. Larsen S, Hilsted J, Philipsen EK, et al: A comparative study of microvascular complications in patients with secondary and type 1 diabetes. Diabet Med 7:815-818, 1990.
10. Catalano PM, Tyzbir ED, Wolfe RR, et al: Carbohydrate metabolism during pregnancy in control subjects with gestational diabetes. Am J Physio] 264:E60-E67, 1993.
11. Kjos SL, Buchanan TA, Greenspoon JS, et al: Gestational diabetes mellitus: The prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am JObstet Gynecol 163:93-98,1990.
12. O'Sullivan JB: Diabetes mellitus after GDM. Diabetes 40:131-135, 1993.
13. Harris MI: Impaired glucose tolerance in the U.S. population. Diabetes Care 12:464-474, 1989.
14. Keen H, Harrett R, McCartney P: The ten-year follow-up of the Bedford survey (1962-1972): Glucose tolerance and diabetes. Diabetologia 22:73-78, 1982.
15. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
16. Haffner SM, Valdez RA, Hazuda HP, et al: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992.
17. Bjorntorp P: Abdominal fat distribution and the metabolic syndrome. J Cardiovasc Pharmacol 20(suppl):26-28, 1992.
18. Wu JT: Review of diabetes: Identification of markers for early detection, glycémie control, and monitoring clinical complications. J Clin Lab Anal 7:293-300, 1993.
19. Shield JP, Poyser K, Hunt L, et al: Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes. Arch Dis Child 71:443-445, 1994.
20. Starkman HS, Soeldner JS, Gleason RE: Oral glucose tolerance-relationship with hemoglobin Ale. Diabetes Res Clin Pract 6:343, 1987.
21. Bergman RN, Steil GM, Bradley DC, et al: Modeling of insulin action in vivo. Annu Rev Physiol 54:861-883, 1992.
22. Ganda OP, Srikanta S, Brink SJ, et al: Differential sensitivity to beta cell secretagogues in "early" type 1 diabetes. Diabetes 33:516, 1984.
23. Bergman RN: Lily lecture 1989. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:15121527, 1989.
24. Martin BC, Warram JH, Krolewski AS, et al: Role of glucose and insulin resistance in development of type II diabetes mellitus: Results of a 25-year follow-up study. Lancet 340:925-929, 1992.
25. Gepts W: The pathology of the pancreas in human diabetes, in Andreani D, Federlin KF, DiMario U, et al (eds):Immunology in Diabetes. London, Kimpton Publishers, 1984, p 21.
26. Atkinson MA, Maclaren NK: Islet cell autoantigens in insulindependent diabetes. JClin Invest 92:1608-1616, 1993.
27. Blasi C, Pierelli F, Rispoli E, et al: Wolfram's syndrome: A clinical, diagnostic and interpretative contribution. Diabetes Care 9:521,1986.
28. Feingold KR, Lee TH, Chug MY, et al: Muscle capillary basement membrane width in patients with Vacor-induced diabetes mellitus. JClin Invest 78:102, 1986.
29. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl JMed 331:1428-1436, 1994.
30. Eisenbarth GS: Type I diabetes mellitus: A chronic autoimmune disease. N Engl JMed 314:1360,1986.
31. Schatz D, Maclaren N: The natural history of pre-type 1 diabetes. Curr Opin Endocrinol Diabetes 2:31-37, 1995.
32. Nagata M, Santamaria D, Kawamura T, et al: Evidence for the role of CD8t cytotoxic T cells in the destruction of pancreatic B cells in nonobese-diabetic mice. JImmunol 152:2042-2059, 1994.
33. Foulis AK, Liddle CN, Farquharson MA, et al: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: A 25 year review of death in patients under 20 years of age in the United Kingdom. Diabetologia 29:267-274, 1986.
34. Makino S, Harada M, Kishimoto Y, et al: Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp Anim 35:495, 1986.
35. Jackson RA, Buse JB, Rifai R, et al: Two genes required for diabetes in BB rats. JExp Med 159:1629, 1984.
36. Thorsby E, Roonningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377,993.
37. Nepom GT: Immunogenetics and IDDM. Diabetes Metab Rev 1:93-103, 1993.
38. Kockum I, Wassmuth R, Holmberg E, et al: HLA-DQ primarily confers protection and HLA-DR susceptibility in type 1 (insulindependent) diabetes studied in population-based affected families and controls. Am /Hum Genet 53:150-167, 1993.
39. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604, 1987.
40. Sanjeevi CB, Kockum I, Lernmark A: The role of the major histocompatibility complex in insulin-dependent diabetes mellitus. Curr Opin Endocrinol Diabetes 2:3-11, 1995.
41. Brown JH, Jardetzky TS, Gorga JC, et al: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39, 1993.
42. Davies JL, Kawaguchi Y, Bennett ST, et al: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994.
43. Bain SC, Prins JB, Hearne CM, et al: Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nat Genet 2:212-215, 1992.
44. Wicker LS, Todd JA, Prins JB, et al: Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and IddlO, protect nonobese diabetic mice from diabetes. JExp Med 180:1705-1713, 1994.
45. Barnett AH, Eff C, Leslie RDG, et al: Diabetes in identical twins: A study of 200 pairs. DiabetoJogia 20:87-93, 1981.
46. Blom L, Dahlquist G, Nystrom L, et al: The Swedish childhood diabetes study-social and perinatal determinants for diabetes in childhood. Diabetologia 32:7, 1989.
47. Bowman MA, Leiter EH, Atkinson MA: Prevention of diabetes in the NOD mouse: Implications for therapeutic intervention in human disease. Immunol Today 15:115-120, 1994.
48. Menser MA, Forrest JM, Brensby RD: Rubella infection and diabetes mellitus. Lancet 1:57, 1981.
49. Karounos DG, Molinsky JS, Thomas JW: Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. JImmunol 150:3080-3085, 1993.
50. Yoon JW, London WT, Curfman BL, et al: Coxsackie virus B4 produces transient diabetes in non-human primates. Diabetes 35:712, 1986.
51. Atkinson MA, Bowman MA, Campbell L, et al: Immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin dependent diabetes. JClin Invest 94:2125-2129, 1994.
52. Gerstein HC: Cow's milk exposure and type 1 diabetes mellitus. Diabetes Care 17:13-19, 1994.
53. Oldstone MB: Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulindependent diabetes mellitus while maintaining general immune competence. JExp Med 171:2077-2089, 1990.
54. Srikanta S, Ganda OP, Soeldner JS, et al: First-degree relatives of patients with type I diabetes: Islet cell antibodies and abnormal insulin secretion. N Engl JMed 313:461, 1985.
55. Bottazzo GF, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279-1283, 1974.
56. Baekkeskov S, Aanstoot H, Christgau S, et al: Identification of the 64 k autoantigen in insulin dependent diabetes as the GABAsynthesizing enzyme glutamic acid decarboxylase. Nature 347:151156, 1990.
57. Palmer JP, McCulloch DK: Prediction and prevention of IDDM-1991. Diabetes 40:943-947, 1991.
58. Solimena M, Folli F, Aparisi R, et al: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560, 1990.
59. Gale EAM, Bottazzo GF: Can we predict type I (insulin-dependent) diabetes? In Krall L (ed): World Book of Diabetes in Practice. Amsterdam, Elsevier, 1985, p 25.
60. Gorsuch AN, Spencer KM, Lister J, et al: Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet 2:1363, 1981.
61. Thai AC, Eisenbarth GS: Natural history of IDDM. Diabetes Rev 1:114,1993.
62. Irvine WJ, Gray RS, Steel JM: Islet cell antibody as a marker for early stage type I diabetes mellitus, in Irvine WJ (ed): The Immunology of Diabetes. Edinburgh, Teviot Publishing, 1980, p 117.
63. Ziegler AG, Ziegler R, Vardi P, et al: Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 38:1320-1325, 1989.
64. Atkinson MA, Maclaren NK, Luchetta R: Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933-937, 1990.
65. Nayak RC, Omar MAK, Rabizadeh A, et al: "Cytoplasmic" islet cell antibodies: Evidence that the target antigen is asialoglycoconjugate. Diabetes 34:617, 1985.
66. Ziegler R, Jackson RA, Ziegler AG, et al: Type 1 diabetes: Polygenic inheritance, multiple autoantigens and "dual" parameter prediction. J Autoimmun 3:69-74, 1990.
67. Gotfredsen CF, Buschard K, Frandsen EK: Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28:933-935, 1985.
68. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 341:927-928, 1993.
69. Harris MI: Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 6:703-719, 1990.
70. Anonymous: Diabetes in the United States; A Strategy/or Prevention. Atlanta, Ga, Centers for Disease Control and Prevention, US Department of Health and Human Services, 1994.
71. Leslie RDG, Pyke DA: Genetics of diabetes, in Albert! KGGM, Krall LP (eds):The Diabetes Annual, vol 3. New York, Elsevier, 1987, p 39.
72. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes (Banting lecture). Diabetes 43:1066-1084, 1994.
73. Lilloja S, Mott DM, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians. N Engl JMed 329:19881992, 1993.
74. Martin BC, Warram JH, Rosner B, et al: Familial clustering of insulin sensitivity. Diabetes 41:850-854, 1992.
75. Alvarsson M, Grill VE, Wajngot A, et al: Long-term stability of low insulin response to glucose in non-diabetic subjects. Acta Endocrinol 127:33-37, 1992.
76. Vague P, Moulin J: The defective glucose sensitivity of the beta-cell in non-insulin dependent diabetes: Improvement after 20 hours of normoglycemia. Metabolism 31:139, 1982.
77. Giugliano D, Cerciello T, Giannetti G, et al: Impaired insulin secretion in diabetes mellitus I: The effect of alpha-adrenergic inhibition. Pharmacol Res Commun 14:217, 1982.
78. Olefsky JM, Reaven GM: Insulin binding in diabetes: Relationships with plasma insulin levels and insulin sensitivity. Diabetes 26:680688, 1977.
79. Kolterman OG, Gray RS, Griffin J, et al: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest 68:957-969, 1981.
80. Kahn CR: Insulin resistance, insulin insensitivity, and insulin unresponsiveness: A necessary distinction. Metabolism 27:1893-1902, 1978.
81. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1-5, 1994.
82. Sun XJ, Rothenberg P, Kahn CR, et al: The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991.
83. Keller SR, Kitagawa K, Aebersold R, et al: Isolation and characterization of the 160,000-Da phosphotyrosyl protein, a putative participant in insulin signaling. JBiol Chem 266:12817-12820, 1991.
84. Sun XJ, Miralpeix M, Myers MG Jr, et al: The expression and function of IRS-1 in insulin signal transmission. JBiol Chem 267:2266222672, 1992.
85. Kühne MR, Pawson T, Lienhard GE, et al: The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 268:11479-11481, 1993.
86. Myers MG Jr, Sun XJ, White MF: The IRS-1 signaling system. TIBS 19:289-294, 1994.
87. Boulton TG, Nye SH, Robbins DJ, et al: ERKs: a family of proteinserine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675, 1991.
88. Avruch J, Zhang XF, Kyriakis JM: Raf meets Ras: Completing the framework of a signal transduction pathway. TIBS 19:279-284, 1994.
89. Obermaier-Kusser B, White MF, Pongratz DE, et al: A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with noninsulin-dependent diabetes mellitus. JBiol Chem 264:9497-9504, 1989.
90. Shulman GI, Rothman DL, Jue R, et al: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl JMed 322:223-228, 1990.
91. DeFronzo RA: The triumvirate B-cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 37:667-687, 1988.
92. Almind K, Bjorbaek C, Vestergaard H, et al: Amino acid polymor-phisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828-832, 1993.
93. Flier JS: Lilly lecture: Syndromes of insulin resistance. From patient to gene and back again. Diabetes 41:1207-1219, 1992.
94. Bogardus C: Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Diabetes Care 16:228-231, 1993.
95. Kahn BB, Flier JS: Regulation of glucose-transporter gene expression in vitro and in vivo. Diabetes Care 13:198-208, 1990.
96. Bonadonna RC, Groop LC, Simonson DC, et al: Free fatty acid and glucose metabolism in human aging: Evidence for operation of the Rändle cycle. Am JPhysiol 266:E501-E509, 1994.
97. Leahy }L, Bonner-Weir S, Weir G: B-cell dysfunction induced by chronic hyperglycemia-Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442-445, 1992.
98. Garvey WT, Olefsky JM, Matthaei S, et al: Glucose and insulin coregulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 262:189-197, 1987.
99. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. JBiol Chem 266:4706-4712, 1991.
100. Peters LL, Barker JE: Novel inheritance of the murine severe combined anemia and thrombocytopenia (Scat) phenotype. Cell 74:135-142, 1993.
101. Srinivas PR, Wagner AS, Reddy LV, et al: Serum alpha 2-HSglycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7:1445-1455, 1993.
102. Maddux BA, Sbraccia P, Kumakura S, et al: Membrane glycoprotein PC-1 in the insulin resistance of non-insulin dependent diabetes mellitus. Nature 373:448-451, 1995.
103. Reynet C, Kahn CR: Rad: A member of the ras family overexpressed in muscle of type II diabetic humans. Science 262:1441-1444, 1993.
104. Sims EAH, Danforth E Jr, Horton ES, et al: Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29:457, 1973.
105. Liu G, Coulston A, Chen Y-D, et al: Does a day-long absolute hypoinsulinemia characterize the patient with non-insulin dependent diabetes mellitus? Metabolism 32:754, 1983.
106. Porte D: Beta-cells in type II diabetes mellitus. Diabetes 40:166-180, 1990.
107. Robertson RP, Porte D Jr: The glucose receptor: A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest 52:870, 1976.
108. Palmer JP, Benson JW, Walter RM, et al: Arginine-stimulated acute phase of insulin and glucagon secretion in diabetes subjects. JCJin Invest 58:565, 1976.
109. Weir GC: Glucagon-like peptide-1 (GLP-1): A piece of the incretin puzzle (editorial, comment). JClin Invest 95:1, 1995.
110. Boyd AE 3d, Aguilar-Bryan J, et al: Sulfonylurea signal transduction. Recent Prog Horm Res 47:299-316, 1991.
111. Knowler WC, Pettitt DJ, Saad MF, et al: Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis. Diabetes Metab Rev 6:1-27, 1990.
112. Tager HS: Lilly lecture 1983: Abnormal products of the human insulin gene. Diabetes 33:693-699, 1984.
113. Steiner DF, Tager HS, Chan SJ, et al: Lesson learned from molecular biology of insulin-gene mutations. Diabetes Care 13:600-609, 1990.
114. Kahn CR, Megyesi K, Roth J: Nonsuppressible insulin-like activity of human serum: A potent inhibitor of insulin degradation. J Clin Invest 57:739-745, 1976.
115. Taylor SI, Accili D, Cama A, et al: Unusual forms of insulin resistance. Annu Rev Med 42:373-379, 1991.
116. Taylor SI: Lilly lecture: Molecular mechanisms of insulin resistanceLessons from patients with mutations in the insulin receptor gene. Diabetes 41:1473-1490, 1992.
117. Fajans SS, Bell GI, Bowden DW: MODY: A model for the study of the molecular genetics of NIDDM. J Lab Clin Med 119:206-210, 1992.
118. Froguel P, Zouali H, Vionnet N, et al: Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Bngl JMed 328:697-702, 1993.
119. Hattersley AT, Turner RC, Permutt MA, et al: Linkage of type 2 diabetes to the glucokinase gene. Lancet 339:1307-1310, 1992.
120. Pilkis SJ, Weber IT, Harrison RW, et al: Glucokinase: Structural analysis of a protein involved in susceptibility to diabetes. J Biol Chem 269:21925-21928, 1994.
121. Bell GI, Xiang KS, Newman MV, et al: Gene for non-insulindependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sei U S A 88:1484-1488, 1991.
122. Vaxillaire M, Vionnet N, Vigouroux C, et al: Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes 43:389-395, 1994.
123. Van den Ouweland JMW, Lemkes HPJ, Ruitenbeek W, et al: Mutation in mitochondrial tRNA (Leu, UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368-371, 1992.